Suboxone’s active ingredient, buprenorphine, is detectable in urine for 1 to 7 days after your last dose. Its main breakdown product can linger even longer, up to 14 days. The exact window depends on how long you’ve been taking Suboxone, your dose, your metabolism, and which type of test is used.
Standard Detection Windows
Buprenorphine itself typically shows up in urine for about 1 to 7 days. But your body converts buprenorphine into a breakdown product called norbuprenorphine, and labs often test for both. Norbuprenorphine can be detected for up to 14 days after your last dose, which effectively doubles the window compared to the parent drug alone.
If you’ve been taking Suboxone daily for weeks or months, expect the longer end of these ranges. Buprenorphine has an unusually wide elimination half-life, with reported averages ranging from 3 to 44 hours depending on the individual. That variability means two people on the same dose can clear it at very different rates. Only about 10 to 30 percent of a dose leaves through urine; the rest is eliminated through stool, which is one reason urinary levels can be unpredictable.
How Test Type Affects Results
Standard workplace drug panels testing for opioids (the kind that screen for heroin, oxycodone, or codeine) will not detect buprenorphine. It requires a separate, specific test. If you’re being tested, it’s worth knowing which kind is being used, because the cutoff levels vary significantly.
Initial screening tests (immunoassays) use a cutoff of 5 ng/mL, meaning anything below that concentration reads as negative. If the screen comes back positive, labs run a confirmation test using more precise methods. Workplace confirmation testing uses a 10 ng/mL cutoff for buprenorphine and also checks for norbuprenorphine. Clinical and pain management settings use much lower cutoffs: 2 ng/mL for buprenorphine and 5 ng/mL for norbuprenorphine. Lower cutoffs make it easier to detect trace amounts, which extends the effective detection window by a day or two.
Factors That Extend or Shorten the Window
Several things shift where you fall in that 1-to-14-day range:
- Duration of use. Buprenorphine accumulates in body fat over time. Someone who took a single dose may test clean in 2 to 3 days, while a long-term daily user could test positive for the full 7 to 14 days.
- Dose. Higher doses produce higher urinary concentrations, which take longer to drop below the test cutoff.
- Metabolism and body composition. Buprenorphine is processed by the liver. People with faster metabolisms, lower body fat, and good liver function tend to clear it more quickly.
- Hydration. Dilute urine lowers the concentration of any substance, potentially pushing a borderline result below the cutoff. Very concentrated urine does the opposite.
- Formulation. This matters enormously. Sublingual Suboxone films or tablets follow the standard 7-to-14-day window. But the long-acting monthly injection (Sublocade) is a completely different story. Because it releases buprenorphine slowly from a depot under the skin, patients can test positive for 12 months or longer after their last injection.
False Positives on Buprenorphine Tests
If you aren’t taking Suboxone but tested positive for buprenorphine, there’s a documented explanation worth knowing about. High-dose morphine can trigger a false positive on the initial immunoassay screening test. In one clinical case, a patient consistently tested positive for buprenorphine while on morphine, but every confirmation test came back clean. When morphine was stopped and replaced with oxycodone, the false positives disappeared. When morphine was restarted, they came back.
This cross-reactivity appears to occur when morphine levels in urine are very high (roughly 15,000 to 28,000 ng/mL). It only affects the initial screening test, not the more precise confirmation methods. If you believe your result is a false positive, requesting confirmation testing through mass spectrometry will give a definitive answer.
What About the Naloxone in Suboxone?
Suboxone contains both buprenorphine and naloxone, but naloxone is poorly absorbed when taken under the tongue as directed. Very little enters the bloodstream, and even less reaches urine in meaningful amounts. Standard drug tests do not screen for naloxone, and its presence or absence in a urine sample has no practical effect on your test results. The detection question is really about buprenorphine and norbuprenorphine alone.